ReviewBone marrow transplantation2007

Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma.

C Gisselbrecht et al.PubMed ↗Publisher ↗

No numbers read from the abstract.